XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2

Cash, Cash Equivalents and Marketable Securities

9 Months Ended

Sep. 30, 2021

Investments Debt And Equity Securities [Abstract]

Cash, Cash Equivalents and Marketable Securities

Note 5. Cash, Cash Equivalents and Marketable Securities

The following tables summarize the Company’s cash, cash equivalents and marketable securities as of September 30, 2021 and December 31, 2020.

As of September 30, 2021
		Amortized Cost				Unrealized Gain				Unrealized (Loss)				Fair Value
Cash and cash equivalents		$	37,995,008			$	—			$	—			$	37,995,008
Marketable securities:
U.S. Treasury Bonds			1,001,506				—				(426	)			1,001,080
Total cash, cash equivalents, and marketable securities		$	38,996,514			$	—			$	(426	)		$	38,996,088

As of December 31, 2020
		Amortized Cost				Unrealized Gain				Unrealized (Loss)				Fair Value
Cash and cash equivalents		$	4,241,937			$	—			$	—			$	4,241,937
Marketable securities:
U.S. Treasury Bonds			18,388,970				—				(2,810	)			18,386,160
Total cash, cash equivalents, and marketable securities		$	22,630,907			$	—			$	(2,810	)		$	22,628,097

X

- Definition

The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-URI http://asc.fasb.org/topic&trid=2196928

+ Details

Name:	us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration